Anti-addiction drug ibogaine on trial

Abstract

By the end of the month, the US National Institute on Drug Abuse (NIDA) will decide whether to proceed with plans for a phase I clinical trial to test the safety of ibogaine, a controversial new drug, for treating drug addiction in humans. Anecdotal reports of use in humans and …